Style | Citing Format |
---|---|
MLA | Sahrai H, et al.. "Thromboprophylaxis for Coagulopathy Related to Covid-19 in Pediatrics: A Narrative Review." Pediatric Drugs, vol. 25, no. 4, 2023, pp. 443-452. |
APA | Sahrai H, Hemmatighavshough M, Shahrabi M, Jafarirouhi AH, Solduzian M (2023). Thromboprophylaxis for Coagulopathy Related to Covid-19 in Pediatrics: A Narrative Review. Pediatric Drugs, 25(4), 443-452. |
Chicago | Sahrai H, Hemmatighavshough M, Shahrabi M, Jafarirouhi AH, Solduzian M. "Thromboprophylaxis for Coagulopathy Related to Covid-19 in Pediatrics: A Narrative Review." Pediatric Drugs 25, no. 4 (2023): 443-452. |
Harvard | Sahrai H et al. (2023) 'Thromboprophylaxis for Coagulopathy Related to Covid-19 in Pediatrics: A Narrative Review', Pediatric Drugs, 25(4), pp. 443-452. |
Vancouver | Sahrai H, Hemmatighavshough M, Shahrabi M, Jafarirouhi AH, Solduzian M. Thromboprophylaxis for Coagulopathy Related to Covid-19 in Pediatrics: A Narrative Review. Pediatric Drugs. 2023;25(4):443-452. |
BibTex | @article{ author = {Sahrai H and Hemmatighavshough M and Shahrabi M and Jafarirouhi AH and Solduzian M}, title = {Thromboprophylaxis for Coagulopathy Related to Covid-19 in Pediatrics: A Narrative Review}, journal = {Pediatric Drugs}, volume = {25}, number = {4}, pages = {443-452}, year = {2023} } |
RIS | TY - JOUR AU - Sahrai H AU - Hemmatighavshough M AU - Shahrabi M AU - Jafarirouhi AH AU - Solduzian M TI - Thromboprophylaxis for Coagulopathy Related to Covid-19 in Pediatrics: A Narrative Review JO - Pediatric Drugs VL - 25 IS - 4 SP - 443 EP - 452 PY - 2023 ER - |